Centamin Egypt Limited
23 January 2003
CENTAMIN EGYPT LIMITED ('CENTAMIN' OR THE 'COMPANY')
LISTED OPTIONS FULLY UNDERWRITTEN
Centamin has entered into agreements for the underwriting of the exercise of its
111,244,446 listed options which are due to expire on 3 March 2003. The options
can be exercised at any time on or before that date at an exercise price of
A$0.20 per share.
The total amount raised by the exercise of all 111,244,446 options at A$0.20 per
share will be A$22,248,889 to be applied to the Sukari Gold project in Egypt.
The underwriters and sub-underwriters will be paid an aggregate fee of 5 per
cent of the amount to be underwritten as at 3 February 2003 and standard
termination clauses apply (some of which are referred to below).
The underwriters are Williams de Broe Plc, Argonaut Capital Limited and Southern
Cross Equities Limited, who are individually underwriting the exercise of 50 per
cent, 25 per cent and 25 per cent Respectively, of the total amount of 3 March
2003 options that remain unexercised, as notified by the Company in writing to
the Underwriters as at 6pm WST on the 3 February 2003.
The Company has applied for 111,244,446 ordinary shares of no par value to be
admitted to trading on the Alternative Investment Market of the London Stock
Exchange under a block admission. These shares will rank pari passu with
existing ordinary shares. It is expected that the block admission will become
effective on 29 January 2003.
Other Terms of Underwriting Agreements
Under the terms of each underwriting agreement, each underwriter has the right
to appoint sub underwriters to sub underwrite some or all of the underwriter's
share of the shortfall. In the event of a shortfall the underwriter has the
right to have the shortfall shares issued to the underwriter, a sub underwriter
or to allottees nominated by the underwriter.
Williams de Broe Plc and Argonaut Capital Limited have the right to terminate
their respective underwriting agreements if a variety of circumstances occur
affecting the company including:
(a) the gold price falling below US$315 per ounce.
(b) the ASX/S&P 200 All Ordinaries Index, the FT-100 Share Index or the
ASX/S&P Materials Index falling to a level which is 10% or more below its
level at the close of trading on the last Business Day immediately before
the date of the Agreement.
(c) An out break of hostilities involving Australia, the US or a number
of other specified countries.
(d) Regulatory or legal breaches involving the Company.
(e) An adverse change occurring affecting the Company.
(f) Insolvency events occurring or suspension on the ASX or a prescribed
occurrence occurring.
Southern Cross Equities Limited has the right to terminate its underwriting
agreement in a variety of circumstances which are substantially similar to those
in the Williams de Broe and Argonaut underwriting agreements.
Enquiries:
Josef El Raghy Leesa Peters
Centamin Egypt Ltd Capital PR
Tel: + 61 (0) 8 9316 2640/ 0418 333 444 Tel: +44 (0) 20 7618 7889/07812159885
josef@centamin.com.au leesa@capitalww.com
Louis Castro
Williams de Broe Plc
Tel: + 44 (0) 20 7588 7511
louis.castro@wdebroe.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.